Literature DB >> 19715878

Surgical risk factors associated with lung transplantation.

M Paradela1, D González, I Parente, R Fernández, M M De La Torre, M Delgado, J A García, E Fieira, C Bonhome, J M B Maté.   

Abstract

BACKGROUND: Despite years of experience with lung transplantation, perioperative morbidity rates remain high. The objective of this study was to analyze our series of lung transplant recipients, seeking to identify possible intra- and postoperative risk factors associated with mortality. PATIENTS AND METHODS: We performed a descriptive, retrospective study of 224 consecutive patients undergoing lung transplantation over a period of 112 months; we excluded retransplant procedures. We gathered details of the surgical procedure and postoperative period in the recovery unit. Univariate analysis using the chi-square test identified variables associated with the incidence of mortality.
RESULTS: From 1999 to 2008, we performed 224 lung transplants, including 66% in men and 34% in women. Their overall mean age was 49.9 +/- 13.5 years. The conditions that led to transplantation were pulmonary fibrosis (38.4%); chronic obstructive pulmonary disease emphysema (29%); cystic fibrosis (10.7%); bronchiectasis (8.9%); pulmonary hypertension (3.1%); and other diseases (9.9%). A total of 124 (55.4%) patients underwent single and 100 (44.6%) received sequential bilateral lung transplantations. Surgical risk factors were identified in 51.3% of the cases, the most frequent being hemorrhage (25.3%), followed by severe pulmonary hypertension (14.7%) and cardiopulmonary bypass (12.1%). Greater perioperative mortality was detected among patients with surgical risk factors, namely, significantly related to cardiopulmonary bypass, pulmonary hypertension, and air leak. A higher frequency of surgical risk factors was observed among patients with bilateral lung transplantations and longer procedures, but they were not associated with greater perioperative mortality. Reoperation was necessary in 16 patients (7.2%), mainly owing to bleeding, it was not significantly related to mortality risk.
CONCLUSIONS: The incidence of surgical risk factors in lung transplantation was high, especially in bilateral lung transplantations and prolonged procedures. Postoperative bleeding requiring reoperation was not frequent and not associated with increased preoperative mortality in our series.

Entities:  

Mesh:

Year:  2009        PMID: 19715878     DOI: 10.1016/j.transproceed.2009.06.016

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Renal relevant radiology: imaging in kidney transplantation.

Authors:  Asif Sharfuddin
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 2.  Established and potential predictors of blood loss during lung transplant surgery.

Authors:  Pascal Oechslin; Marco P Zalunardo; Ilhan Inci; Martin Schlaepfer; Bastian Grande
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Bronchial artery revascularization in lung transplantation: a systematic review and meta-analysis.

Authors:  Danial Ahmad; Thomas J O'Malley; Andrew M Jordan; Elizabeth J Maynes; Abhiraj Saxena; Kyle W Prochno; Taufiek K Rajab; Howard T Massey; Richard C Daly; Vakhtang Tchantchaleishvili
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

Review 4.  Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations.

Authors:  C Randall Lane; Adriano R Tonelli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-09

5.  Practical guidelines: lung transplantation in patients with cystic fibrosis.

Authors:  T O Hirche; C Knoop; H Hebestreit; D Shimmin; A Solé; J S Elborn; H Ellemunter; P Aurora; M Hogardt; T O F Wagner
Journal:  Pulm Med       Date:  2014-03-30

6.  First Lung Transplantation in Jehovah's Witness Patient in Latin America.

Authors:  Liliana Fernandez-Trujillo; Fernando Sanabria; Diego F Bautista; Mauricio Velazquez; Indira Cujiño; Eric Tafur; Daniel Arboleda; Valeria Zuñiga-Restrepo; Willian Martinez
Journal:  Clin Med Insights Case Rep       Date:  2020-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.